Cardioprotective effects of PARP inhibitors for platinum-agent induced cardiotoxicity
{{output}}
Poly(ADP-ribose) polymerase (PARP) inhibitors may have cardioprotective properties. This study aimed to evaluate the potential cardioprotective effects of PARP inhibitors in patients with epithelial ovarian cancer treated with platinum-based chemotherapeutic a... ...
